Attorney General James Continues Fight to Maintain Access to Reproductive Health Care at Supreme Court

Posted to Applied Web NY on Tue, 09/08/2020 - 15:41

NEW YORK – New York Attorney General Letitia James today led a multistate coalition of 23 attorneys general in supporting legal action against the Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS) for attempting to increase the risk that women nationwide will contract the coronavirus disease 2019 (COVID-19) as they seek abortions in their state. In an amicus brief filed in support of the plaintiffs in FDA et al. v. American College of Obstetricians and Gynecologists et al. in the U.S. Supreme Court, Attorney General James leads the coalition in encouraging the court to reject a request from the Trump Administration to halt a preliminary injunction issued by a district court in July and thereby reinstate an FDA requirement that forces women to appear in person in a clinical setting to receive a drug known as mifepristone for an early abortion. The coalition has argued in the past — and continues to argue in today’s amicus brief — that the drug should be readily accessible via telehealth and mail delivery, so as to not potentially expose women to COVID-19 by requiring unnecessary travel. 

Bulletin assigned to: